Department of Gastroenterology and Hepatology, Ruhr-University Bochum, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil gGmbH, Bochum 44789, Germany.
Institute of Pathology, Ruhr-University Bochum, Bochum 44789, Germany.
World J Gastroenterol. 2019 Feb 28;25(8):967-979. doi: 10.3748/wjg.v25.i8.967.
Drug toxicity is a common and even serious problem in the gastrointestinal tract that is thought to be caused by a broad spectrum of agents. Although withdrawal of the causative agent would cure the disease knowledge is scarce and mostly derives from case reports and series.
To investigate potential triggers of drug-induced colitis (DiC).
We conducted a retrospective, observational case control study. Patients were assigned to DiC or one of two age- and gender-matched control groups (non-inflammatory controls and inflammatory colitis of another cause) based on histopathological findings. Histopathology was reassessed in a subset of patients (28 DiC with atherosclerosis, DiC without atherosclerosis and ischaemic colitis each) for validation purposes. Medical history was collected from the electronic database and patient records. Statistical analysis included chi-squared test, -test, logistic and multivariate regression models.
Drug-induced colitis was detected in 211 endoscopically sampled biopsy specimens of the colon mucosa (7% of all screened colonoscopic biopsy samples); a total of 633 patients were included equally matched throughout the three groups (291 males, mean age: 62.1 ± 16.1 years). In the univariate analysis, DiC was associated with diuretics, dihydropyridines, glycosides, ASS, platelet aggregation inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), statins and fibrates, and with atherosclerosis, particularly coronary heart disease, and hyperlipoproteinaemia. Echocardiographic parameters did not show substantial differences. In the multivariate analysis only fibrates [odds ratio (OR) = 9.1], NSAIDs (OR = 6.7) and atherosclerosis (OR = 2.1) proved to be associated with DiC. Both DiC reassessment groups presented milder inflammation than ischaemic colitis. The DiC patients with atherosclerosis exhibited histological features from both DiC without atherosclerosis and ischaemic colitis.
Several drugs indicated for the treatment of cardiovascular and related diseases are associated with DiC. Atherosclerosis and microcirculatory disturbances seem to play an important pathogenetic role.
药物毒性是胃肠道中一种常见甚至严重的问题,被认为是由广泛的药物引起的。尽管停用致病药物可以治愈疾病,但相关知识却很少,主要来源于病例报告和系列研究。
研究药物诱导结肠炎(DiC)的潜在触发因素。
我们进行了一项回顾性、观察性病例对照研究。根据组织病理学发现,将患者分配到 DiC 或两个年龄和性别匹配的对照组(非炎症对照组和另一种原因引起的炎症性结肠炎)。为了验证目的,对一部分患者(28 例伴有动脉粥样硬化的 DiC、无动脉粥样硬化的 DiC 和缺血性结肠炎各 14 例)进行了组织病理学复查。从电子数据库和患者记录中收集了病史。统计分析包括卡方检验、t 检验、逻辑和多变量回归模型。
在 211 例结肠镜活检结肠黏膜样本中检测到药物诱导性结肠炎(占所有筛查结肠镜活检样本的 7%);共有 633 例患者在三组中平均匹配(男性 291 例,平均年龄 62.1±16.1 岁)。在单因素分析中,DiC 与利尿剂、二氢吡啶类、糖苷、ASS、血小板聚集抑制剂、非甾体抗炎药(NSAIDs)、他汀类药物和贝特类药物有关,还与动脉粥样硬化特别是冠心病和高脂血症有关。超声心动图参数没有显示出明显的差异。在多变量分析中,只有贝特类药物(比值比[OR] = 9.1)、NSAIDs(OR = 6.7)和动脉粥样硬化(OR = 2.1)与 DiC 相关。两组 DiC 复查组的炎症均比缺血性结肠炎轻。伴有动脉粥样硬化的 DiC 患者表现出既无动脉粥样硬化也无缺血性结肠炎的组织学特征。
一些用于治疗心血管和相关疾病的药物与 DiC 有关。动脉粥样硬化和微循环障碍似乎起着重要的发病作用。